ICCC
NASDAQ
$11.15
Immucell Corp (ICCC)
ImmuCell Corporation, an animal health company, develops, manufactures and markets products that improve the health and productivity of dairy and beef cattle in the United States and internationally. The company is headquartered in Portland, Maine.
Sector:
Healthcare
Industry:
Biotechnology
Target: $14 (+25.56%)
Market Cap
$97M
Free Cash Flow Yield
3.48%
Beta (5Y)
0.30
Price Chart
Valuation
Market Cap$97M
P/S3.24
P/B3.64
Profitability
Total Revenue (TTM)$30M
Gross Profit (TTM)$13M
EBITDA$5.13M
Profit Margin18.8%
Operating Margin19%
EPS-$0.06
Financial Health
Debt-to-Equity29.9%
Free Cash Flow Yield3.48%
Growth & Risk
EPS 5Y CAGR-26.43%
Revenue 5Y CAGR+2.75%
Beta (5Y)0.30
Sharpe Ratio1.17